Anti-PD-1 antibody can bind to PD-1 expressed on T cells, while anti-PD-L1 antibody can bind to PD-L1 expressed on cancer cells, thus preventing PD-1 expressed on T cells from binding to PD-L1 expressed on tumor cells, allowing T cells to kill cancer cells (117). This evidence concerns the gene PDCD1 and cancer.